Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,920
Closed -$303K 1994
2024
Q4
$303K Sell
5,920
-1,278
-18% -$66.2K ﹤0.01% 1590
2024
Q3
$320K Buy
7,198
+2,132
+42% +$93.2K ﹤0.01% 1589
2024
Q2
$204K Buy
+5,066
New +$192K ﹤0.01% 1814
2022
Q2
Sell
-21,335
Closed -$1.04M 865
2022
Q1
$1.04M Sell
21,335
-704
-3% -$35.6K 0.02% 837
2021
Q4
$1.05M Buy
+22,039
New +$1.04M 0.02% 812
2021
Q3
Sell
-26,576
Closed -$1.17M 821
2021
Q2
$1.17M Buy
+26,576
New +$1.25M 0.02% 704
2017
Q4
Sell
-4,840
Closed -$223K 877
2017
Q3
$223K Buy
+4,840
New +$210K 0.01% 708

Other funds holding SNV

Atria Investments's SNV Position: Q1 2025 in Review

Atria Investments sold out of Synovus (SNV) in Q1 2025, closing a stake of 5,920 shares — an estimated $303K sold.

Atria Investments first reported a position in SNV in Q3 2017 and held it in 7 quarters. The position peaked at $1.17M in Q2 2021. 478 funds tracked by Wall St. Rank hold SNV as of Q1 2025.

  • Atria Investments reported no remaining Synovus position as of Q1 2025 after selling out during the quarter.
  • Atria Investments sold 5,920 Synovus shares in Q1 2025, an estimated $303K.
  • Atria Investments first reported a position in Synovus in Q3 2017 and held it in 7 quarters.
  • Atria Investments's Synovus position peaked at $1.17M in Q2 2021.
  • 478 funds tracked by Wall St. Rank held Synovus as of Q1 2025.

Based on Atria Investments's 13F filing for Q1 2025, filed 6 May 2025.